These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 33895752)

  • 1. Influence of various risk factors on the level of ST2 biomarker in patients with heart failure and diabetes mellitus type 2.
    Rudyk IS; Medentseva OO; Gasanov IC; Babichev DP
    Pol Merkur Lekarski; 2021 Apr; 49(290):95-98. PubMed ID: 33895752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of serum calcium and heart failure with preserved ejection fraction in patients with type 2 diabetes.
    Li J; Wu N; Dai W; Jiang L; Li Y; Li S; Wen Z
    Cardiovasc Diabetol; 2016 Oct; 15(1):140. PubMed ID: 27716206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of diabetes on the predictive value of heart failure biomarkers.
    Alonso N; Lupón J; Barallat J; de Antonio M; Domingo M; Zamora E; Moliner P; Galán A; Santesmases J; Pastor C; Mauricio D; Bayes-Genis A
    Cardiovasc Diabetol; 2016 Nov; 15(1):151. PubMed ID: 27809845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial).
    Trippel TD; Van Linthout S; Westermann D; Lindhorst R; Sandek A; Ernst S; Bobenko A; Kasner M; Spillmann F; González A; López B; Ravassa S; Pieske B; Paulus WJ; Díez J; Edelmann F; Tschöpe C
    Eur J Heart Fail; 2018 Mar; 20(3):460-470. PubMed ID: 28891228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome.
    Ruocco G; Evangelista I; Franci B; Lucani B; Martini S; Nuti R; Palazzuoli A
    J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):81-90. PubMed ID: 30540645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [THE ROLE OF MARKER FIBROSIS ST2 AND ANGIOTENZINOGEN GENE POLYMORPHISM IN HEART FAILURE PROGRESSING IN PATIENTS WITH TYPE 2 DIABETES MELLITUS].
    Rudyk I; Medentseva O
    Georgian Med News; 2018 Feb; (Issue):105-112. PubMed ID: 29578435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance in heart failure: differences between patients with reduced and preserved left ventricular ejection fraction.
    Scherbakov N; Bauer M; Sandek A; Szabó T; Töpper A; Jankowska EA; Springer J; von Haehling S; Anker SD; Lainscak M; Engeli S; Düngen HD; Doehner W
    Eur J Heart Fail; 2015 Oct; 17(10):1015-21. PubMed ID: 26198713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
    Yap J; Tay WT; Teng TK; Anand I; Richards AM; Ling LH; MacDonald MR; Chandramouli C; Tromp J; Siswanto BB; ; Zile M; McMurray J; Lam CSP
    J Am Heart Assoc; 2019 Sep; 8(17):e013114. PubMed ID: 31431116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive biomarkers for death and rehospitalization in comorbid frail elderly heart failure patients.
    Pacho C; Domingo M; Núñez R; Lupón J; Núñez J; Barallat J; Moliner P; de Antonio M; Santesmases J; Cediel G; Roura S; Pastor MC; Tor J; Bayes-Genis A
    BMC Geriatr; 2018 May; 18(1):109. PubMed ID: 29743019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential prognostic impact of type 2 diabetes mellitus in women and men with heart failure with preserved ejection fraction.
    Palau P; Bertomeu-González V; Sanchis J; Soler M; de la Espriella R; Domínguez E; Santas E; Núñez E; Chorro FJ; Miñana G; Bayés-Genís A; Núñez J
    Rev Esp Cardiol (Engl Ed); 2020 Jun; 73(6):463-470. PubMed ID: 31629690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.
    Santhanakrishnan R; Chong JP; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Richards AM; Lam CS
    Eur J Heart Fail; 2012 Dec; 14(12):1338-47. PubMed ID: 22869458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left atrial rather than left ventricular impaired mechanics are associated with the pro-fibrotic ST2 marker and outcomes in heart failure with preserved ejection fraction.
    Nagy AI; Hage C; Merkely B; Donal E; Daubert JC; Linde C; Lund LH; Manouras A
    J Intern Med; 2018 Apr; 283(4):380-391. PubMed ID: 29430747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of glycemic variability with left ventricular diastolic function in type 2 diabetes mellitus.
    Yokota S; Tanaka H; Mochizuki Y; Soga F; Yamashita K; Tanaka Y; Shono A; Suzuki M; Sumimoto K; Mukai J; Suto M; Takada H; Matsumoto K; Hirota Y; Ogawa W; Hirata KI
    Cardiovasc Diabetol; 2019 Dec; 18(1):166. PubMed ID: 31805945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of luseogliflozin and alpha-glucosidase inhibitor on heart failure with preserved ejection fraction in diabetic patients: rationale and design of the MUSCAT-HF randomised controlled trial.
    Ejiri K; Miyoshi T; Nakamura K; Sakuragi S; Munemasa M; Namba S; Takaishi A; Ito H
    BMJ Open; 2019 Mar; 9(3):e026590. PubMed ID: 30928954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood Pressure, Congestion and Heart Failure with Preserved Ejection Fraction Among Patients with and Without Type 2 Diabetes Mellitus. A Cluster Analysis Approach from the Observational Registry DICUMAP.
    Arévalo-Lorido JC; Carretero-Gómez J; Aramburu-Bodas O; Grau-Amoros J; Torres-Cortada G; Camafort-Babkowski M
    High Blood Press Cardiovasc Prev; 2020 Oct; 27(5):399-408. PubMed ID: 32770527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction].
    Cao J; Jin XJ; Zhou J; Chen ZY; Xu DL; Yang XC; Dong W; Li LW; Luo J; Chen L; Fu M; Zhou JM; Ge JB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):875-881. PubMed ID: 31744276
    [No Abstract]   [Full Text] [Related]  

  • 17. Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction.
    Sanders-van Wijk S; van Empel V; Davarzani N; Maeder MT; Handschin R; Pfisterer ME; Brunner-La Rocca HP;
    Eur J Heart Fail; 2015 Oct; 17(10):1006-14. PubMed ID: 26472682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of endothelial progenitor cells and apoptotic endothelial cell-derived microparticles in chronic heart failure patients with preserved and reduced left ventricular ejection fraction.
    Berezin AE; Kremzer AA; Martovitskaya YV; Berezina TA; Gromenko EA
    EBioMedicine; 2016 Feb; 4():86-94. PubMed ID: 26981573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of chronic heart failure with preserved left ventricular ejection fraction in patients with hypertension and isolated mild diastolic dysfunction.
    Brzyżkiewicz H; Konduracka E; Gajos G; Janion M
    Pol Arch Med Wewn; 2016; 126(1-2):12-8. PubMed ID: 26810565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidities and their implications in patients with and without type 2 diabetes mellitus and heart failure with preserved ejection fraction. Findings from the rica registry.
    Arévalo-Lorido JC; Carretero-Gómez J; Gómez-Huelgas R; Llácer P; Manzano L; Quesada Simón MA; Roca Villanueva B; González Franco Á; Cepeda JM; Montero Pérez-Barquero M
    Int J Clin Pract; 2021 Jan; 75(1):e13661. PubMed ID: 32770841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.